FDA Panel to Evaluate 7 Popular Peptides for Compounding Substances ListByAshley Gallagher, MAJuly 6th 2026
FDA Approves Skyrizi for Pediatric Plaque Psoriasis, Psoriatic ArthritisByAshley Gallagher, MAJune 29th 2026
FDA Approves Olezarsen as First Treatment to Reduce Pancreatitis Risk in Adults with HypertriglyceridemiaByBrian NowosielskiJune 24th 2026
Pharmacy Law Lowdown: GLP-1 CompoundingByBrian Nowosielski,Dae Lee, PharmD, Esq, CPBS ,Lucas Morgan, EsqJune 23rd 2026